Objective
The goal of the present study was to compare the myocardial protection
obtained with histidine-tryptophan-ketoglutarate (HTK) cardioplegic solution
(Custodiol
®
) and with intermittent hypothermic blood
solution.
Methods
Two homogenous groups of 25 children with acyanotic congenital heart disease
who underwent total correction with mean aortic clamping time of 60 minutes
were evaluated in this randomized study. Troponin and creatine kinase-MB
curves, vasoactive-inotropic score, and left ventricular function were
obtained by echocardiogram in each group. The values were correlated and
presented through graphs and tables after adequate statistical
treatment.
Results
It was observed that values of all the studied variables varied over time,
but there was no difference between the groups.
Conclusion
We conclude that in patients with acyanotic congenital cardiopathies
submitted to total surgical correction, mean aortic clamping time around one
hour, and cardiopulmonary bypass with moderate hypothermia, the HTK
crystalloid cardioplegic solution offers the same myocardial protection as
the cold-blood hyperkalemic cardioplegic solution analyzed, according to the
variables considered in our study model.